Brief: Granules Receives VAI Classification After US FDA Inspection
31/03/2026 09:29
March 31 (Reuters) - Granules India Ltd GRAN.NS: GRANULES - RECEIVES VAI CLASSIFICATION FOLLOWING US FDA INSPECTION GRANULES - INSPECTION IS NOW CLOSED, NO REGULATORY ACTION HAS BEEN RECOMMENDED Source text: ID:nBSE1HyjKN Further company coverage: GRAN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake